KGbio
Laurensia Lolita is a Clinical Trial Associate at PT Kalbe Genexine Biologics and a Math Private Tutor at Gold Star Education. Previously, Laurensia worked as a COVID-19 PCR Laboratory Coordinator and Molecular Biologist at MRCCC Siloam Hospitals Semanggi. Laurensia also has experience as a Research Intern at National Science and Technology Development Agency (NSTDA). Laurensia holds a Bachelor of Science (B.S.) in Biotechnology from Atma Jaya Catholic University of Indonesia.
This person is not in the org chart
This person is not in any teams
KGbio
KGbio is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside the US/Canada, Western Europe and China. The business model revolves around in-licensing novel biologics and select biosimilars in oncology and high-specialty therapeutic areas (typically pre-IND or early clinical stage), with the objective to out-license them in target geographies after finishing clinical development as well as regulatory and reimbursement approvals. Platforms of interest currently include Fc-fusion proteins, antibodies, bispecifics, ADCs, cell therapies and therapeutic vaccines. The company is backed by Asian pharma companies Kalbe (market cap US$5.5 billion) and Genexine (market cap US$1.3 billion) and US private equity giant General Atlantic (AUM US$ 78 billion).